Drug firm Astrazeneca is challenging plans by the New Zealand Government's drug-buying agency Pharmac to reduce the subsidy on their combination inhaler – Symbicort to match the subsidy on competing firm GSK’s Seretide. This court action coincides with renewed warnings about these drugs from the United States FDA.
Read full article here: http://www.radionz.co.nz/news/national/92303/pharmac-taken-to-court-over-asthma-subsidy
Posted: Wed 30 Nov 2011
